Roche Holding Ltd · SIX:RO
Roche — Exane BNP Paribas 3rd DILS CEO Conference 2023
8 slides from Roche's conference presentation, December 2023
Slide 1: Roche Diagnostics update
Roche Diagnostics update Exane BNP Paribas, December 2023 Dr. Birgit Masjost, Investor Relations Officer Roche Diagnostics
Slide 2: YTD Sep 2023: Diagnostics Division sales
YTD Sep 2023: Diagnostics Division sales Strong base business growth, partially offsetting COVID-19 sales decrease 2023 2022 Change in % Excl. CHFm CHFm CHF CER C191 Diagnostics Division 10,431 13,848 -25 -18 7 Core Lab 5,836 5,833 0 9 Molecular Lab 1,647 2,735 -40 -35 Pathology Lab 1,046 975 7 15 D
Slide 3: Largest installed base worldwide with significant growth potential
Largest installed base worldwide with significant growth potential Strong growth in 2022 is a key pilar for continuous sales growth +4% cobas® 4000/6000/80001 +122% cobas® pro / pure +3% Lab SW Solutions +9% Preanalytics / Connectivity HE600 +12% +30% cobas® 5800/6800/8800 BenchMark ULTRA/ ULTRAPLUS
Slide 4: Core Lab menu expansion driving future growth
Core Lab menu expansion driving future growth >240 assays running on >100k installed cobas® serum work area instruments Launches in 2021, 2022, 2023 and upcoming4 Immuno chemistry assays Clinical chemistry assays EBV EBNA IgG (CE) IGRA SARS-CoV-2 Interferon Gamma Anti-HEV IgG and Fentanyl3 (CE, US)
Slide 5: Elecsys Amyloid Plasma Panel clinical results
Elecsys® Amyloid Plasma Panel clinical results Received FDA approval for Elecsys ® CSF AD assays pTau181 /Abeta 42 1 2 3 Triage Confirmation Therapy Selection & Therapy Patients undergoing initial evaluation Patients referred for amyloid Patients identified for future therapies for non-specific cogn
Slide 6: cobas i601 analytical mass spectrometry unit and assay menu
cobas® i601 analytical mass spectrometry unit and assay menu Fully integrated and automated solution with more than 40 IVD assays at launch Seamless integration into cobas® pro integrated solutions IVD assay menu of more than 60 assays in 2 launch waves1 Steroids Vitamin D Therapeutic Drug Monitorin
Slide 7: Diagnostics key launches 2023
Diagnostics key launches 2023 Area Product Description Markets Status Modular transportation system, integrated into the existing cobas connection modules, allowing for overhead CCM Vertical Global sample transportation over different work areas or different floors enabling effective use of lab spac
Slide 8: Doing now what patients need next
Doing now what patients need next
Roche Holding — Exane BNP Paribas 3rd DILS CEO Conference 2023 on 6ix